Inventiva S.A.
IVA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001756594
No open-market purchases or sales by Inventiva S.A. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $319.5M in total; no superinvestor holds it.
Other share classesIVEVF
Q2 2021 vs. Q1 2021
How the institutions holding Inventiva S.A. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 13 | 14 | +1 |
| Shares | 1.62M | 1.56M | −58.5K (−3.6%) |
| Value | $23.8M | $21.3M | −$2.50M (−10.5%) |
New holders (4)
Institutions that held Inventiva S.A. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Yiheng Capital Management, L.P. | 26,016 | $355.0K | 0.01% |
| Citigroup Inc | 12,000 | $163.0K | 0.00% |
| UBS Group AG | 397 | $5.00K | 0.00% |
| Geneos Wealth Management Inc. | 100 | $1.00K | 0.00% |
Sold out (3)
Institutions that held Inventiva S.A. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Alyeska Investment Group, L.P. | 46,437 | $683.0K |
| Advisor Group Holdings, Inc. | 750 | $11.0K |
| Steward Partners Investment Advisory, LLC | 200 | $2.94K |